One of the most common waterborne diseases worldwide is cryptosporidiosis, a parasitic disease affecting the small intestine and possibly our airways. It is a common cause of diarrhea in HIV-positive patients, who are known to have lower immunity. Now, Kazeem Oare Okosun from Vaal University of Technology in South Africa, and colleagues from Pakistan and Nigeria, have developed a new model and numerical simulations to determine the optimal combination of prevention and treatment strategies for controlling both diseases in patients who have been co-infected. Their results, recently published in EPJ Plus, show a positive impact on the treatment and prevention for cryptosporidiosis alone, for HIV-AIDS alone, or for both together.
Although there are many mathematical models on HIV infection, there are far fewer for cryptosporidiosis. And, until now, there was no co-infection model for cryptosporidiosis and HIV-AIDS. The authors examined what happens to patients presenting both infections when they are subjected to five prevention methods and treatments for cryptosporidiosis alone, for HIV-AIDS alone and for both at specific intervals. They then explored their effects on the co-infection by performing numerical analyses.
They found that cryptosporidiosis preventions and treatment alone had no significant impact on reducing HIV-AIDS-related problems. By contrast, the prevention and treatment strategy for HIV-AIDS had a significant positive impact on the co-infected patients. Finally, applying both strategies at the same time resulted in reduction in all cases. They also found that, when both diseases were treated at the same time, it had a positive impact in cryptosporidiosis patients and on the level of environmental contamination, with no difference in the co-infected cases.
Reference: K.O. Okosun , M.A. Khan, E. Bonyah, S.T. Ogunlade (2017), On the dynamics of HIV-AIDS and cryptosporidiosis, European Physical Journal Plus, DOI 10.1140/epjp/i2017-11625-3
Source: Springer
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.